Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Baseline cystatin C measurement is a potent predictor of adverse cardiovascular outcomes following ACS: A PROVE IT - TIMI 22 analysis

Baseline cystatin C measurement is a potent predictor of adverse cardiovascular outcomes following ACS: A PROVE IT - TIMI 22 analysis. Circulation. 2006; 114(18):II-418.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.